Sugi Predict

Sugi Predict / Targets / SLC30A6

SLC30A6

Zinc transporter 6 · Q6NXT4 · SLC30A6 on Sugi Atlas →

0 patent compounds predicted against SLC30A6, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to SLC30A6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes PHASE4COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus PHASE3COMPLETED
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Anti-TNFα to Delay or Prevent Progression to Stage 3 T1D PHASE2WITHDRAWN
Oral N-acetylglucosamine in Crohn's Disease PHASE2NOT_YET_RECRUITING
Safety Study of High Doses of Zinc in ALS Patients PHASE1/PHASE2COMPLETED
Zinc Sulphate in Treatment Fibrosis in HBV Patient Receiving Antiviral Therapy PHASE2NOT_YET_RECRUITING
Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis PHASE1UNKNOWN
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors PHASE1RECRUITING
A Study to Evaluate SIMPONI (Golimumab) Therapy in Children, Adolescents and Young Adults With Pre-Symptomatic Type 1 Diabetes PHASE1COMPLETED
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men nanCOMPLETED
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study nanCOMPLETED
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes nanCOMPLETED
Zn Supplementation in HIV Immunological Non Responders nanRECRUITING
Zinc Sulfate Acceptability nanCOMPLETED
Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers nanCOMPLETED
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Natural History Study of SLC25A46 Mutation-related Mitochondriopathy nanCOMPLETED
An Evaluation of Zinc Status Biomarkers nanCOMPLETED
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) nanCOMPLETED
Gene Expression in Inflammatory Bowel Disease nanENROLLING_BY_INVITATION
Evaluation of Zinc Intake on Essential Fatty Acid Metabolism nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
The Efficacy of Zinc-biofortified Rice in Bangladeshi Children nanCOMPLETED
UK Islet Autoantibody Registry nanRECRUITING
Efficacy of Zinc Fortified Fermented Wheat Flour nanCOMPLETED
Copper Supplementation in Cirrhosis nanRECRUITING
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a SLC30A6 binder may also engage these)

ProteinNameSimilarity
Q0VC54 — 1.000 Q0VC54 →
Q5ZIH3 — 1.000 Q5ZIH3 →
Q8BJM5 — 0.998 Q8BJM5 →
Q6AZN8 — 0.997 Q6AZN8 →
Q5I0B2 — 0.994 Q5I0B2 →
Q6GPY1 — 0.993 Q6GPY1 →
Q6P0D1 — 0.982 Q6P0D1 →
Q6ICY4 — 0.965 Q6ICY4 →
Q8NE79 — 0.959 Q8NE79 →
Q5RH73 — 0.957 Q5RH73 →
Q3BCU4 — 0.956 Q3BCU4 →
B8Q0B2 — 0.956 B8Q0B2 →
Q9R1D7 — 0.955 Q9R1D7 →
Q9ES83 — 0.955 Q9ES83 →
Q8R455 — 0.954 Q8R455 →
Q7L1W4 — 0.954 Q7L1W4 →
Q6DIX1 — 0.953 Q6DIX1 →
Q8CIF6 — 0.953 Q8CIF6 →
Q8BM85 — 0.953 Q8BM85 →
E9Q4Z2 — 0.953 E9Q4Z2 →
Q3TDN0 — 0.953 Q3TDN0 →
Q6R5J2 — 0.952 Q6R5J2 →
Q8BPM2 — 0.952 Q8BPM2 →
Q61143 — 0.952 Q61143 →
Q5F3F5 — 0.952 Q5F3F5 →
Q9DG23 — 0.952 Q9DG23 →
Q5R7Z3 — 0.952 Q5R7Z3 →
Q8C8N2 — 0.952 Q8C8N2 →
Q9Y5W8 — 0.952 Q9Y5W8 →
Q640Z1 — 0.952 Q640Z1 →